B. Otten

833 total citations
27 papers, 601 citations indexed

About

B. Otten is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, B. Otten has authored 27 papers receiving a total of 601 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Surgery. Recurrent topics in B. Otten's work include Sexual Differentiation and Disorders (6 papers), Protein Tyrosine Phosphatases (6 papers) and RNA modifications and cancer (4 papers). B. Otten is often cited by papers focused on Sexual Differentiation and Disorders (6 papers), Protein Tyrosine Phosphatases (6 papers) and RNA modifications and cancer (4 papers). B. Otten collaborates with scholars based in Netherlands, Australia and Germany. B. Otten's co-authors include C. Noordam, I. van der Bürgt, G. B. A. Stoelinga, Fred A. Exterkate, Jan M. Wit, J.H. Veerkamp, Bart Boersma, A. R. M. M. Hermus, A. G. H. Smals and Joop P. van den Bergh and has published in prestigious journals such as Journal of Bacteriology, Osteoporosis International and European Journal of Endocrinology.

In The Last Decade

B. Otten

25 papers receiving 573 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Otten Netherlands 14 346 171 159 139 70 27 601
Frank G. Hustmyer United States 11 204 0.6× 91 0.5× 89 0.6× 149 1.1× 268 3.8× 14 692
Green Australia 8 77 0.2× 50 0.3× 26 0.2× 96 0.7× 41 0.6× 12 452
Ali Murat Ceyhan Türkiye 12 90 0.3× 72 0.4× 112 0.7× 28 0.2× 11 0.2× 32 487
Xiaobo Zhang China 8 100 0.3× 209 1.2× 40 0.3× 45 0.3× 8 0.1× 18 468
Zaynab Alourfi Syria 11 47 0.1× 43 0.3× 315 2.0× 49 0.4× 36 0.5× 24 520
Alliny Souza Bastos Brazil 12 81 0.2× 38 0.2× 43 0.3× 54 0.4× 73 1.0× 14 460
Masao Maeyama Japan 13 117 0.3× 54 0.3× 112 0.7× 81 0.6× 4 0.1× 58 539
Ulrich Züegel Germany 10 87 0.3× 37 0.2× 186 1.2× 70 0.5× 5 0.1× 11 525
Kristen L. Williams United States 7 116 0.3× 57 0.3× 90 0.6× 213 1.5× 7 0.1× 31 499
Takayasu Arima Japan 14 104 0.3× 26 0.2× 57 0.4× 41 0.3× 16 0.2× 28 384

Countries citing papers authored by B. Otten

Since Specialization
Citations

This map shows the geographic impact of B. Otten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Otten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Otten more than expected).

Fields of papers citing papers by B. Otten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Otten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Otten. The network helps show where B. Otten may publish in the future.

Co-authorship network of co-authors of B. Otten

This figure shows the co-authorship network connecting the top 25 collaborators of B. Otten. A scholar is included among the top collaborators of B. Otten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Otten. B. Otten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Noordam, C., et al.. (2008). Response to Growth Hormone Treatment and Final Height in Noonan Syndrome in a Large Cohort of Patients in the KIGS Database. Journal of Pediatric Endocrinology and Metabolism. 21(3). 267–73. 45 indexed citations
2.
Otten, B., et al.. (2008). Case 2: A 6‐year‐old boy with precocious puberty (Case Presentation). Acta Paediatrica. 98(1). 6–7. 5 indexed citations
3.
Cools, Martine, Leendert H. J. Looijenga, B. Otten, K.P. Wolffenbuttel, & S. L. S. Drop. (2008). Genetische basis, terminologie en het risico voor de ontwikkeling van kiemceltumoren bij stoornissen in de geslachtsontwikkeling. Tijdschrift voor kindergeneeskunde. 76(3). 92–104. 3 indexed citations
4.
Noordam, C., et al.. (2008). Long-term GH treatment improves adult height in children with Noonan syndrome with and without mutations in protein tyrosine phosphatase, non-receptor-type 11. European Journal of Endocrinology. 159(3). 203–208. 65 indexed citations
5.
Darendelıler, Feyza, Pontus Larsson, Olcay Neyzi, et al.. (2003). Growth Hormone Treatment in Aarskog Syndrome: Analysis of the KIGS (Pharmacia International Growth Database) Data. Journal of Pediatric Endocrinology and Metabolism. 16(8). 1137–42. 8 indexed citations
6.
Dörr, Helmuth G., Siegfried Zabransky, B. Otten, et al.. (2003). Are Needle-Free Injections a Useful Alternative for Growth Hormone Therapy in Children? Safety and Pharmacokinetics of Growth Hormone Delivered by a New Needle-Free Injection Device Compared to a Fine Gauge Needle. Journal of Pediatric Endocrinology and Metabolism. 16(3). 383–92. 33 indexed citations
7.
Noordam, C., I. van der Bürgt, Han G. Brunner, & B. Otten. (2002). The Relationship between Clinical Severity of Noonan's Syndrome and Growth, Growth Hormone (GH) Secretion and Response to GH Treatment. Journal of Pediatric Endocrinology and Metabolism. 15(2). 175–80. 10 indexed citations
8.
Bergh, Joop P. van den, C. Noordam, J.M. Thijssen, et al.. (2001). Measuring Skeletal Changes with Calcaneal Ultrasound Imaging in Healthy Children and Adults: The Influence of Size and Location of the Region of Interest. Osteoporosis International. 12(11). 970–979. 11 indexed citations
9.
Noordam, C., et al.. (2001). Growth hormone treatment in children with Noonan’s syndrome: four year results of a partly controlled trial. Acta Paediatrica. 90(8). 889–894. 5 indexed citations
10.
Noordam, C., et al.. (2001). Effects of Growth Hormone Treatment on Left Ventricular Dimensions in Children with Noonan’s Syndrome. Hormone Research in Paediatrics. 56(3-4). 110–113. 35 indexed citations
12.
Festen, C, et al.. (1995). Follicular Adenoma of the Thyroid Gland in Children. European Journal of Pediatric Surgery. 5(5). 262–264. 5 indexed citations
13.
Nienhuis, H.E., C. Rongen‐Westerlaken, J.M. Wit, et al.. (1993). Results of Long-Term Therapy with Growth Hormone in Two Dose Regimens in Turner Syndrome. Hormone Research. 39(2). 31–36. 13 indexed citations
14.
Rongen‐Westerlaken, C., et al.. (1993). Effect of growth hormone treatment on craniofacial growth in Turner's syndrome. Acta Paediatrica. 82(4). 364–368. 38 indexed citations
15.
Haraldsson, Ásgeir, et al.. (1993). Antibody deficiency and isolated growth hormone deficiency in a girl with Mulibrey nanism. European Journal of Pediatrics. 152(6). 509–512. 15 indexed citations
16.
Rongen‐Westerlaken, C., J.M. Wit, S.M.P.F. de Muinck Keizer-Schrama, et al.. (1992). Growth hormone treatment in Turner syndrome accelerates growth and skeletal maturation. European Journal of Pediatrics. 151(7). 477–481. 23 indexed citations
17.
Drop, S. L. S., et al.. (1990). Growth Analysis up to Final Height and Psychosocial Adjustment of Treated and Untreated Patients with Precocious Puberty. Hormone Research. 34(5-6). 197–203. 26 indexed citations
18.
Otten, B., et al.. (1983). [A new catheter set for continuous axillary plexus anesthesia].. PubMed. 6(2). 43–6. 1 indexed citations
19.
Zenz, M., S Piepenbrock, B. Otten, Gillis R. Otten, & R. Neuhaus. (1981). [Epidural morphine analgesia. Postoperative period (author's transl)].. PubMed. 30(2). 77–82. 4 indexed citations
20.
Otten, B., et al.. (1981). [Isolated peripheral twelfth nerve paresis following puncture of the internal jugular vein (author's transl)].. PubMed. 30(1). 46–46. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026